trial

TMS Related Biomarker Assessments

NCTId NCT05660018
as of 2026-07-01
at a glance
· Completed
Enrollment 10 (actual)
Primary completion 2025-02-14
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Completed
Enrollment
10 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2023-01-07
Primary completion
2025-02-14
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Sponsors

Investigators

1
Xiaoming Du, PhDPrincipal Investigator

Sites

1 total
Baltimore, United States

Facts & assertions

4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2025-02-14
Status
COMPLETED
relationships
The graph out of here
indication
investigator